Table 6.
Effect of vitamin D treatment on ambulation and lower extremity motor function in patients with stroke who were not within the first 3 months of stroke.
| Vitamin D | |||
|---|---|---|---|
| Control (n = 19) | Vitamin D (n = 19) | p-value | |
| FAC | |||
| Prerehab | 3 (0–4) | 3 (0–4) | 0.692 |
| Postrehab | 3 (0–5) | 3 (0–5) | 0.441 |
| Change | 0 (0–3) | 1 (0–3) | 0.311 |
| BRS | |||
| Prerehab | 3 (1–6) | 4 (1–6) | 0.999 |
| Postrehab | 4 (1–6) | 5 (1–6) | 0.580 |
| Change | 0 (0–2) | 0 (0–3) | 0.169 |
| Vitamin D* levels (ng/mL) | 20 (8–41) | 19 (8–35) | 0.759 |
Values are presented as median (min–max). FAC: Functional ambulation classification, BRS: Brunnstrom recovery stage.